These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 14749143

  • 41. Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes.
    Bell DS, Ovalle F.
    Diabetes Obes Metab; 2004 Sep; 6(5):363-6. PubMed ID: 15287929
    [Abstract] [Full Text] [Related]

  • 42. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.
    Alkharfy KM, Al-Daghri NM, Sabico SB, Al-Othman A, Moharram O, Alokail MS, Al-Saleh Y, Kumar S, Chrousos GP.
    Cardiovasc Diabetol; 2013 Aug 07; 12():113. PubMed ID: 23924389
    [Abstract] [Full Text] [Related]

  • 43. Progress with thiazolidinediones in the management of type 2 diabetes mellitus.
    Meriden T.
    Clin Ther; 2004 Feb 07; 26(2):177-90. PubMed ID: 15038941
    [Abstract] [Full Text] [Related]

  • 44. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
    Stafford JM, Elasy T.
    Vasc Health Risk Manag; 2007 Feb 07; 3(4):503-10. PubMed ID: 17969380
    [Abstract] [Full Text] [Related]

  • 45. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
    Inzucchi SE.
    JAMA; 2002 Jan 16; 287(3):360-72. PubMed ID: 11790216
    [Abstract] [Full Text] [Related]

  • 46. Treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.
    Prescrire Int; 2003 Feb 16; 12(63):28-30. PubMed ID: 12602406
    [Abstract] [Full Text] [Related]

  • 47. The "glitazones": rosiglitazone and pioglitazone.
    Papoushek C.
    J Obstet Gynaecol Can; 2003 Oct 16; 25(10):853-7. PubMed ID: 14532954
    [Abstract] [Full Text] [Related]

  • 48. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
    Seufert J, Lübben G, Dietrich K, Bates PC.
    Clin Ther; 2004 Jun 16; 26(6):805-18. PubMed ID: 15262452
    [Abstract] [Full Text] [Related]

  • 49. Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
    Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B, Diabetes Outcome Progression Trial (ADOPT) Study Group.
    Diabetes Care; 2010 Jan 16; 33(1):177-83. PubMed ID: 19808911
    [Abstract] [Full Text] [Related]

  • 50. Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine.
    Boyda HN, Procyshyn RM, Asiri Y, Wu C, Wang CK, Lo R, Pang CC, Honer WG, Barr AM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():170-6. PubMed ID: 24140931
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.
    Braunstein S.
    Clin Ther; 2003 Jul 03; 25(7):1895-917. PubMed ID: 12946541
    [Abstract] [Full Text] [Related]

  • 56. Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.
    Scheen AJ.
    Drug Saf; 2005 Jul 03; 28(7):601-631. PubMed ID: 27722966
    [Abstract] [Full Text] [Related]

  • 57. Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials.
    Gaitonde P, Hurtado FK, Garhyan P, Chien JY, Schmidt S.
    Clin Pharmacol Ther; 2018 Oct 03; 104(4):699-708. PubMed ID: 29271001
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes].
    MMW Fortschr Med; 2007 Apr 12; 149(15):52-3. PubMed ID: 17668778
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.